Arcato reports positive Phase 1 trial results for ARC-001 Gel

Vascarta commences NIH phase I clinical study of VAS-101 in sickle cell disease

Amplitude Therapeutics and Lilly collaborate on trans-amplifying RNA vaccine development for infectious diseases

BioArctic and Mesenkia sign research collaboration for glioblastoma antibody project

Tolerance Bio licenses clinical-stage IL-7 therapy from NeoImmuneTech

Merck and Moderna report positive Phase 3 melanoma trial results

Scancell announces UK authorisation for Phase 3 melanoma trial

Initiator Pharma secures two European patents for pudafensine

Resivant Medical reports first patient cases with Cutiva PLUS Skin Closure System

Andelyn Biosciences to develop and manufacture gene therapy AAV9-GM2 for Queen's University to treat GM2 gangliosidoses

Piramal Pharma acquires controlling stake in Yapan Bio

Curavit acquires Lindus Health CRO assets

Hansa Biopharma reports first Australian transplant using Idefirix

WuXi XDC's Singapore site BCM3 facility achieves GMP release

Slingshot Bio introduces ViaComp Ultra Amine